Plasma lysoGb3 useful as biomarker in screening for Fabry disease in patients with mild left ventricular hypertrophy

Back

ESC Premium Access

Plasma lysoGb3 useful as biomarker in screening for Fabry disease in patients with mild left ventricular hypertrophy

Session: Cardiomyopathy in Fabry disease

Topic: Infiltrative Myocardial Disease

Speaker: Doctor M. Kagimoto (Yokohama, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Minako Kagimoto

Yokohama city university hospital, Yokohama (Japan)

0 follower

5 more presentations in this session

Hypertrophy of unaffected cardiomyocytes concurs to severity of cardiomyopathy in female patients with Fabry disease

Speaker: Associate Professor C. Chimenti (Rome, IT)

Access

Abstract

Speckle-tracking analysis of right ventricular function in Fabry disease - is left ventricle the only diseased chamber ?

Speaker: Doctor J. Liao (Taipei, TW)

Access

Abstract

Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers

Speaker: Mr J. Muentze (Wuerzburg, DE)

Access

Abstract

Cardiac magnetic resonance imaging in Fabry cardiomyopathy

Speaker: Professor S. Moiseev (Moscow, RU)

Novel electrocardiographic parameters for the detection of Fabry Disease - A comparative multi-centre study

Speaker: Doctor M. Namdar (Geneva, CH)

Access the full session

Cardiomyopathy in Fabry disease

Speakers: Doctor M. Kagimoto, Associate Professor C. Chimenti, Doctor J. Liao, Mr J. Muentze, Professor S. Moiseev...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources